Anzeige
Mehr »
Login
Donnerstag, 02.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
"Special Situation"-Aktie mit Multi-Tenbagger-Potenzial im heißesten Rohstoff-Markt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
19 Leser
Artikel bewerten:
(0)

AAHRPP Accredits First Organizations in Europe

Four others, in U.S. and China, also earn accreditation

WASHINGTON, Sept. 22, 2015 /PRNewswire/ -- The Association for the Accreditation of Human Research Protection Programs today announced that it has accredited six more research organizations, including its first two in Europe. Both are in Belgium.

Logo - http://photos.prnewswire.com/prnh/20130625/NY37243LOGO

Three U.S. organizations and a hospital in China also are among the latest to earn AAHRPP accreditation.

The newly accredited organizations are:

  • Children's Mercy Hospital, Kansas City, Missouri
  • Cliniques Universitaires de Bruxelles- Hôpital Erasme, Brussels, Belgium
  • Cliniques Universitaires Saint-Luc, Brussels, Belgium
  • Renal Research Institute, LLC, New York, New York
  • Texas Tech University Health Sciences Center, Lubbock, Texas
  • The Third Xiangya Hospital of Central South University, Changsha, Hunan Province, China

"These latest accreditations expand AAHRPP's influence in yet another key region for clinical research," AAHRPP President and CEO Elyse I. Summers said. "With accredited organizations in Asia, Europe, Latin America and North America, we are strengthening protections for research participants around the globe and across all sectors of the research enterprise."

AAHRPP-accredited organizations include universities, academic medical centers, community and specialty hospitals, independent institutional review boards, contract research organizations, dedicated research sites, research sponsors, and public health departments.

To earn AAHRPP accreditation, organizations must demonstrate that they have built extensive safeguards into every level of their research operation and that they adhere to high standards for research. In today's global, collaborative research enterprise, organizations increasingly rely on AAHRPP accreditation status to help identify trusted research partners.

To date, AAHRPP has accredited more than 215 organizations in 46 states, Belgium, Canada, China, India, Mexico, Republic of Korea, Saudi Arabia, Singapore, Taiwan, and Thailand. All major U.S. independent institutional review boards have earned AAHRPP accreditation. In addition, more than 60 percent of U.S. research-intensive universities and over 65 percent of U.S. medical schools are either AAHRPP accredited or have begun the accreditation process. The National Institutes of Health, the world's largest public funder of research, has earned accreditation, as has Pfizer, Inc., the largest industry sponsor of clinical research.

About AAHRPP: A nonprofit organization, AAHRPP provides accreditation for organizations that conduct or review human research and can demonstrate that their protections exceed the safeguards required by the U.S. government. To learn more, visit www.aahrpp.org.

FOR MORE INFORMATION CONTACT:
Sarah Kiskaddon
Director, Global Development and Public Affairs
skiskaddon@aahrpp.org
(202) 783-1112

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2015 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.